A Feasibility Study of Hypoxia Imaging in Patients With Prostate Cancer Using Positron Emission Tomography (PET) With 18F-Fluoroazomycin Arabinoside (18F-FAZA)
The purpose of this study is to look for low levels of oxygen (hypoxia) in prostate cancer
using a special x-ray test called a positron emission tomography (PET)scan. Hypoxia may have
an effect on how prostate cancer grows and responds to treatments like radiation therapy and
chemotherapy. The use of PET scans to measure hypoxia may be better and simpler than the
methods used previously.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society